Nurse Practitioner, Primary Care · Hackensack, NJ
NPI
1073050076
Since 2017
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
20 Prospect Ave Ste 800
Hackensack, NJ, 07601
Phone (201) 343-6676
Groups this clinician bills Medicare through
Medicare paid, 2023
$650
17 services
Medicare patients, 2023
16
Average age 50
Drug cost, 2024
$972K
1,505 prescriptions
Company payments, 2025
$1,514
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Chae D Miller-Westfield prescribed most often to Medicare patients was Lacosamide, with 199 prescriptions and refills. In total Chae D Miller-Westfield wrote 1,505 Medicare prescriptions that cost $972K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lacosamide Generic | 199 | 257 | 57 | $19K |
| Levetiracetam Generic | 118 | 252 | 65 | $5,316 |
| Vimpat Lacosamide | 102 | 120 | 23 | $111K |
| Xcopri Cenobamate | 92 | 96 | 19 | $135K |
| Clonazepam Generic | 86 | 96 | 27 | $545 |
| Phenobarbital Generic | 80 | 100 | 21 | $2,046 |
| Briviact Brivaracetam | 76 | 87 | 22 | $148K |
| Oxcarbazepine Generic | 69 | 129 | 33 | $6,825 |
| Zonisamide Generic | 60 | 89 | 21 | $2,428 |
| Lamotrigine Generic | 48 | 78 | 17 | $677 |
| Clobazam Generic | 40 | 42 | Under 11 | $3,390 |
| Divalproex Sodium Generic | 36 | 62 | 18 | $2,641 |
| Topiramate Generic | 35 | 61 | 17 | $528 |
| Keppra Levetiracetam | 35 | 57 | 15 | $58K |
| Topamax Topiramate | 31 | 47 | Under 11 | $47K |
Brand drugs: 527 claims; generic drugs: 898 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chae D Miller-Westfield $1,514 ($1,514 in general payments such as food, travel and fees) from 9 companies. The largest payer was UCB, Inc. with $577.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.